Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07806279) titled 'Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk' on Sept. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Uppsala University
Condition:
Cardiometabolic Syndrome
Obesity and Cardiovascular Risk
Overweight , Obesity
Intervention:
Drug: Bupropion 150 mg
Dietary Supplement: Lyophilized powder from edible mushrooms
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 30, 2026
Target Sample S...